ASHLEY CRANE: Open Payments
NPI 1811506439 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,660 in 158 payments from 31 companies in 2025. Trend: 2023 $3,407 · 2024 $6,544 · 2025 $3,660
Food & beverage: $3,435Education: $226
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $701 |
| ABBVIE INC. | 17 | $393 |
| Lilly USA, LLC | 20 | $356 |
| Astellas Pharma US Inc | 7 | $285 |
| Novo Nordisk Inc | 12 | $283 |
| Phathom Pharmaceuticals, Inc. | 15 | $282 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $182 |
| Novartis Pharmaceuticals Corporation | 4 | $122 |
| Exact Sciences Corporation | 5 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $106 |
Products named: AIRSUPRA, VOQUEZNA, UBRELVY, JARDIANCE, MOUNJARO, Wegovy, FARXIGA, LEQVIO.
Industry payments across MA — which companies pay providers there.
